Springer Health+ IME
@SpringerIME
Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.
加入 March 2016
2.8K 正在关注 19.8K 粉丝
Breaking from EASL 2026: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP.
